These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 106770)

  • 1. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.
    Barry AL; Schoenknecht FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.
    de Girolami PC; Maher LA; Booth MT; St George DM
    J Clin Microbiol; 1980 Oct; 12(4):546-9. PubMed ID: 6999021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical susceptibility to cephalothin and cefamandole of a Klebsiella pneumoniae isolate producing extended-spectrum beta-lactamase (TEM-3).
    Gaillot O; Mallea M; Philippon A; Pages JM; Simonet M
    J Antimicrob Chemother; 1996 Jan; 37(1):194-6. PubMed ID: 8647766
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of agar-disc-diffusion tests with minimum inhibitory concentrations of cefonicid (SK&F 75073) and cephalothin.
    Grappel SF; Guarini JR; Actor P; Weisbach JA
    J Antibiot (Tokyo); 1980 Jan; 33(1):85-7. PubMed ID: 7372555
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN; Bollinger M
    Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefamandole---a review of chemistry and microbiology.
    Kaiser GV; Gorman M; Webber JA
    J Infect Dis; 1978 May; 137 Suppl():S10-S16. PubMed ID: 565798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE; Cornere BM; MacCulloch D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.